Skip to main content
2025 SECO Annual Congress Main banner
Back

SECO 2025

AOA CE HOURS

COPE-CL

OD FL

OD IL

OD SC

OD TX

AOA-PARA

NCLE

OPT AZ

OPT FL

OPT GA

OPT KY

OPT NC-CL

OPT NV

OPT SC

OPT TN

502 - SECO Contact Lens Summit Part II - Defeating Dropouts: Optimizing Contact Lenses for Ongoing Success

Wednesday, February 26, 2025
3:30 PM – 5:30 PM EST
Location: Georgia World Congress Center, Sidney Marcus Auditorium
CE Hours: 2
Despite advancements in contact lens technologies, many individuals discontinue contact lens wear due to discomfort, dryness, and unmet vision needs. This lecture provides insights into defeating dropouts, keeping individuals happy in contact lenses by optimizing comfort and vision. Attendees will gain practical tools and knowledge to retain current patients, gain new patients, and promote sustained growth in their contact lens practice.

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:
  • Realize how poor fitting lenses can contribute to contact lens dryness and discomfort and ultimately dropouts and how to approach lens fitting with an eye on long term success
  • Learn how improper care regimens and wearing habits can contribute to contact lens dryness and discomfort and ultimately dropouts and how to recommend the best replacement schedule and care regimen
  • Identify how improperly prescribed contact lenses can hinder patient satisfaction with their vision and how to optimize vision in contact lenses
  • Understand how contact lens wear and dry eye disease have a complex relationship and how to navigate this aspect of lens wear to minimize the impact of contact lens wear on dry eye disease
  • Differentially diagnose dryness and discomfort with contact lenses, how to separate out lens related issues from inherent dryness, and how to approach managing them with a logical approach
  • Discuss options for task specific lens wear to allow the patient that does not want full time wear to stay in lenses
Disclosure(s):
Jason Jedlicka, OD: Bausch and Lomb: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Advisory Committee/Board Member (), Consulting Fees (); Lens dEsign solutions: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (), Royalty Recipient (); Oculus: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); ovitz: Speaker's Bureau (honoraria or other compensation) ()
Melissa Barnett, OD: ABBOptical: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); AbbVie/Allergan: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Acculens: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Azura Ophthalmics: Advisory Committee/Board Member (); Bausch + Lomb: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); BCLA: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bruder: Advisory Committee/Board Member (); Bruno Vision Care: Advisory Committee/Board Member (); CooperVision: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Dompe: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Epion: Advisory Committee/Board Member (); Gas Permeable Lens Institute: Advisory Committee/Board Member (); Johnson & Johnson Vision: Advisory Committee/Board Member (); Lentechs: Advisory Committee/Board Member (); Ocusoft: Advisory Committee/Board Member (); Orasis: Advisory Committee/Board Member (); Percept: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); RVL: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Sjogren's Syndrome Foundation: Advisory Committee/Board Member (); STAPLE program: Speaker's Bureau (honoraria or other compensation) (); Tarsus: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Thea Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Visus Therapeutics: Advisory Committee/Board Member (), Consulting Fees ()
Jason E. Compton, OD, FAAO: Alcon: Speaker's Bureau (honoraria or other compensation) ()
Caity Morrison, OD: Bausch + Lomb: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Tarsus Pharma: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) ()
Roxanne Achong-Coan, OD: CooperVision: Speaker's Bureau (honoraria or other compensation) (); Topcon: Speaker's Bureau (honoraria or other compensation) ()